UAB To Test Potential COVID-19 Vaccine
By BirminghamWatch
The University of Alabama at Birmingham and the biopharmaceutical company Altimmune Inc. will test a potential vaccine for COVID-19, the university announced today.
Testing of the vaccine, AdCOVID, which was developed by the company based in Gaithersburg, Maryland, will begin in mice during the second quarter of this year. That phase of testing, designed to show the immune response to the drug in mice, is expected to take one to two months, UAB said in announcing the collaboration.
The vaccine is given in a single dose of intranasal spray, UAB said. If results of the tests in mice warrant, Altimmune could launch a Phase 1 human safety trial during the third quarter of this year.
The announcement by UAB said Altimmune “has significant experience in the development of intranasal vaccine candidates for respiratory pathogens, including a seasonal and pandemic influenza vaccine and a vaccine for inhalation anthrax.”
“We are eager to collaborate with Altimmune on this important project,” said Frances E. Lund, the Charles H. McCauley Professor and Chair for the UAB Department of Microbiology. “The expertise and infrastructure at UAB will be invaluable to the rapid progression of this vaccine into clinical studies.
Lund said six labs at UAB will work on the project.
Vipin K. Garg, president and CEO of Altimmune, cited UAB’s role in research in virology and immunology. He said the company was founded through a technology license from UAB in 1997.
“It is critical that the biotechnology industry and academic institutions work together to prevent the further spread of COVID-19, and UAB is an ideal partner to support us in this effort,”Garg said.
UAB also has extensive experience in conducting clinical studies of vaccines and has participated in studies sponsored by the Vaccine Evaluation and Trial Unit, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
The vaccine being tested “will activate mucosal and cellular immune responses, as well as a strong antibody response in the blood,” the announcement said.
“If the AdCOVID vaccine candidate is as stable as Altimmune’s influenza and anthrax vaccines candidates, that may allow inexpensive and efficient distribution of the millions of doses needed for widespread vaccination of populations,” the statement said.
Israel and Hamas agree on the ‘first phase’ of Gaza ceasefire deal
The deal raises the possibility that the war may now be over, ending the bloodiest fighting ever between Israelis and Palestinians.
‘Fairyland’ recalls a girl’s life with her poet father in pre-AIDS San Francisco
Alysia Abbott's memoir about growing up in 1970s San Francisco with her gay, single father, has been adapted into a film directed by Andrew Durham and produced by Sofia Coppola.
Los Angeles: Spaghetti Cumbia, a band born from cultural fusion
Photographers and storytellers Karla Gachet and Ivan Kashinsky document cumbia music in Colombia, Mexico, Ecuador, Peru, Argentina and the United States.
What are your holiday shopping plans? NPR wants to hear from you
Is this the season of cutbacks or splurges? As we prepare to cover holiday shopping and deals, NPR wants to hear from you, whatever your plans may be.
Laufey was an ‘odd fish’ in native Iceland. Now she’s a jazz-pop star
The Grammy Award-winning singer and musician had rigorous classical training. Now she's making music that crosses genres: "I've been inspired by Golden Age films, the va-va-voom of it all," she says.
What does Montreal sound like?
World Cafe is kicking off its latest Sense of Place series with a playlist that offers a glimpse of Montreal's lively music scene.
